![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 15, 11412-11417, April 14, 2000
From the Cartilage oligomeric matrix protein (COMP) is a
member of the thrombospondin family of extracellular matrix
glycoproteins. All members of the family contain a highly conserved
region of thrombospondin type 3 sequence repeats that bind calcium. A
mutation in COMP previously identified in a patient with
pseudoachondroplasia resulted in abnormal sequestration of COMP in
distinctive rER vesicles. The mutation, Asp-446
A Cartilage Oligomeric Matrix Protein Mutation Associated with
Pseudoachondroplasia Changes the Structural and Functional Properties
of the Type 3 Domain*
§,
¶,
, and
¶
Research Department, Shriners Hospital for
Children, the § Department of Oral and Molecular Biology,
and the ¶ Department of Biochemistry and Molecular Biology, Oregon
Health Sciences University, Portland, Oregon, 97201
Asn, is located in
the type 3 repeats of the molecule. This region was expressed in a
mammalian culture with and without the mutation to study the structural or functional properties associated with the mutation. The biophysical parameters of the mutant peptide were compared with those of the wild
type and revealed the following difference: secondary structural analysis by circular dichroism showed more
-helix content in the
wild-type peptides. The calcium binding properties of the two peptides
were significantly different; there were 17 calcium ions
bound/wild-type COMP3 peptide compared with 8/mutant peptide. In
addition, wild-type COMP3 had a higher affinity for calcium and bound
calcium more cooperatively. Calcium bound by the wild-type peptide was
reflected in a structural change as indicted by velocity sedimentation.
Thus, the effect of the COMP mutation appears to profoundly alter the
calcium binding properties and may account for the difference observed
in the structure of the type 3 domain. Furthermore, the highly
cooperative binding of calcium to COMP3 suggests that these type 3 sequence repeats form a single protein domain, the thrombospondin type
3 domain.
*
This work was supported by grants from Shriners Hospital for
Children (to H. P. B. and D. R. K.), the R. Blaine
Bramble Medical Research Foundation, the Fred Meyer Charitable Trust,
and by Grant AR45582 from the Department of Health and Human Services.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
503-221-3433; Fax: 503-221-3451; E-mail: hpb@shcc.org.
This article has been cited by other articles:
![]() |
C. B. Carlson, Y. Liu, J. L. Keck, and D. F. Mosher Influences of the N700S Thrombospondin-1 Polymorphism on Protein Structure and Stability J. Biol. Chem., July 18, 2008; 283(29): 20069 - 20076. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Pirog-Garcia, R. S. Meadows, L. Knowles, D. Heinegard, D. J. Thornton, K. E. Kadler, R. P. Boot-Handford, and M. D. Briggs Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP Hum. Mol. Genet., September 1, 2007; 16(17): 2072 - 2088. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schmitz, A. Becker, A. Schmitz, C. Weirich, M. Paulsson, F. Zaucke, and R. Dinser Disruption of Extracellular Matrix Structure May Cause Pseudoachondroplasia Phenotypes in the Absence of Impaired Cartilage Oligomeric Matrix Protein Secretion J. Biol. Chem., October 27, 2006; 281(43): 32587 - 32595. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Misenheimer and D. F. Mosher Biophysical Characterization of the Signature Domains of Thrombospondin-4 and Thrombospondin-2 J. Biol. Chem., December 16, 2005; 280(50): 41229 - 41235. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Holden, D. R. Keene, G. P. Lunstrum, H. P. Bachinger, and W. A. Horton Secretion of Cartilage Oligomeric Matrix Protein Is Affected by the Signal Peptide J. Biol. Chem., April 29, 2005; 280(17): 17172 - 17179. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-l. A. Hannah, T. M. Misenheimer, M. M. Pranghofer, and D. F. Mosher A Polymorphism in Thrombospondin-1 Associated with Familial Premature Coronary Artery Disease Alters Ca2+ Binding J. Biol. Chem., December 10, 2004; 279(50): 51915 - 51922. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Mann, S. Ozbek, J. Engel, M. Paulsson, and R. Wagener Interactions between the Cartilage Oligomeric Matrix Protein and Matrilins: IMPLICATIONS FOR MATRIX ASSEMBLY AND THE PATHOGENESIS OF CHONDRODYSPLASIAS J. Biol. Chem., June 11, 2004; 279(24): 25294 - 25298. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Jakkula, J Lohiniva, A Capone, L Bonafe, M Marti, V Schuster, A Giedion, G Eich, E Boltshauser, L Ala-Kokko, et al. A recurrent R718W mutation in COMP results in multiple epiphyseal dysplasia with mild myopathy: clinical and pathogenetic overlap with collagen IX mutations J. Med. Genet., December 1, 2003; 40(12): 942 - 948. [Full Text] |
||||
![]() |
Y. Hashimoto, T. Tomiyama, Y. Yamano, and H. Mori Mutation (D472Y) in the Type 3 Repeat Domain of Cartilage Oligomeric Matrix Protein Affects Its Early Vesicle Trafficking in Endoplasmic Reticulum and Induces Apoptosis Am. J. Pathol., July 1, 2003; 163(1): 101 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Ballock and R. J. O'Keefe The Biology of the Growth Plate J. Bone Joint Surg. Am., March 31, 2003; 85(4): 715 - 726. [Full Text] [PDF] |
||||
![]() |
B.-l. A. Hannah, T. M. Misenheimer, D. S. Annis, and D. F. Mosher A Polymorphism in Thrombospondin-1 Associated with Familial Premature Coronary Heart Disease Causes a Local Change in Conformation of the Ca2+-binding Repeats J. Biol. Chem., March 7, 2003; 278(11): 8929 - 8934. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Misenheimer, A. J. Hahr, A. C. Harms, D. S. Annis, and D. F. Mosher Disulfide Connectivity of Recombinant C-terminal Region of Human Thrombospondin 2 J. Biol. Chem., November 30, 2001; 276(49): 45882 - 45887. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Holden, R. S. Meadows, K. L. Chapman, M. E. Grant, K. E. Kadler, and M. D. Briggs Cartilage Oligomeric Matrix Protein Interacts with Type IX Collagen, and Disruptions to These Interactions Identify a Pathogenetic Mechanism in a Bone Dysplasia Family J. Biol. Chem., February 16, 2001; 276(8): 6046 - 6055. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Thur, K. Rosenberg, D. P. Nitsche, T. Pihlajamaa, L. Ala-Kokko, D. Heinegard, M. Paulsson, and P. Maurer Mutations in Cartilage Oligomeric Matrix Protein Causing Pseudoachondroplasia and Multiple Epiphyseal Dysplasia Affect Binding of Calcium and Collagen I, II, and IX J. Biol. Chem., February 23, 2001; 276(9): 6083 - 6092. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |